Alkermes (ALKS) Long-Term Investments (2011 - 2026)

Alkermes' (ALKS) quarterly Long-Term Investments came in at $26.4 million in Q1 2026, down 18.1% year-on-year from $32.2 million in Q1 2025, and up 18081.38% on a QoQ basis from $145000.0 in Q4 2025.

Alkermes (ALKS) Long-Term Investments (2011 - 2026) Analysis & Trends

Alkermes (ALKS) has 16 years of Long-Term Investments data on file, last reported at $26.4 million in Q1 2026.

  • On a quarterly basis, Long-Term Investments fell 18.1% year-over-year to $26.4 million in Q1 2026; TTM through Mar 2026 was $26.4 million, a 18.1% decrease from a year earlier, with the FY2025 full-year figure at $145000.0, down 99.8% from the prior year.
  • Long-Term Investments for Q1 2026 stood at $26.4 million, up from $145000.0 in the prior quarter.
  • Over the last five years, Long-Term Investments for ALKS reached as high as $229.8 million in Q1 2022 and fell as low as $145000.0 in Q4 2025.
  • Historically, Long-Term Investments has averaged $81.8 million across 5 years, with a median of $73.1 million in 2024.
  • Across the five-year window, Long-Term Investments jumped 165.85% in 2022 and plunged 99.8% in 2025, its largest moves.
  • Year by year, Long-Term Investments stood at $131.6 million in 2022, then slumped by 69.69% to $39.9 million in 2023, then jumped by 83.39% to $73.1 million in 2024, then plunged by 99.8% to $145000.0 in 2025, then soared by 18081.38% to $26.4 million in 2026.
  • Per Business Quant data, the three most recent Long-Term Investments figures were $26.4 million in Q1 2026, $145000.0 in Q4 2025, and $27.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn -
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 56.09 Mn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 1.32 Bn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - 12.05 Mn
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 146.10 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn -
10 Alkermes 8.78 Bn 8.27 Bn 331.33 Mn 26.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 26.36 Mn
Dec 31, 2025 145,000.00
Sep 30, 2025 27.87 Mn
Jun 30, 2025 38.27 Mn
Mar 31, 2025 32.19 Mn
Dec 31, 2024 73.15 Mn
Sep 30, 2024 18.92 Mn
Jun 30, 2024 86.40 Mn
Mar 31, 2024 62.78 Mn
Dec 31, 2023 39.89 Mn
Sep 30, 2023 106.43 Mn
Jun 30, 2023 78.13 Mn
Mar 31, 2023 92.08 Mn
Dec 31, 2022 131.61 Mn
Sep 30, 2022 166.93 Mn
Jun 30, 2022 179.01 Mn
Mar 31, 2022 229.83 Mn
Dec 31, 2021 229.43 Mn
Sep 30, 2021 187.86 Mn
Jun 30, 2021 131.03 Mn